539680 — GANGA PHARMACEUTICALS Balance Sheet
0.000.00%
- IN₹69.05m
- IN₹84.35m
- IN₹26.37m
- 17
- 26
- 34
- 11
Annual balance sheet for GANGA PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0.29 | 0.298 | 3.02 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 23.3 | 24.3 | 34.5 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | 51.5 | 57.5 | 68.7 |
| Net Property, Plant And Equipment | 6.39 | 6.12 | 6.65 |
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 79.8 | 86.5 | 89.7 |
| Accounts Payable | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 18.9 | 12 | 16 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Total Other Liabilities | |||
| Total Liabilities | 25.3 | 16 | 18.4 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 54.5 | 70.5 | 71.3 |
| Total Liabilities & Shareholders' Equity | 79.8 | 86.5 | 89.7 |
| Total Common Shares Outstanding |